AR-Targeted Therapy and Immunotherapy for TNBC – OncLive
OncLive |
AR-Targeted Therapy and Immunotherapy for TNBC
OncLive Panelists: Adam M. Brufsky, MD, PhD, University of Pittsburgh Cancer Institute; Michael Gnant, MD, Medical University of Vienna; Joyce A. OShaughnessy, MD, Baylor University Medical Center; Hope S. Rugo, MD, University of California San Francisco Helen … |
